These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 10411574

  • 1. Potent and selective human beta(3)-adrenergic receptor antagonists.
    Candelore MR, Deng L, Tota L, Guan XM, Amend A, Liu Y, Newbold R, Cascieri MA, Weber AE.
    J Pharmacol Exp Ther; 1999 Aug; 290(2):649-55. PubMed ID: 10411574
    [Abstract] [Full Text] [Related]

  • 2. Isomeric-activity ratios of trimetoquinol enantiomers on beta-adrenergic receptor subtypes: functional and biochemical studies.
    Fraundorfer PF, Lezama EJ, Salazar-Bookaman MM, Fertel RH, Miller DD, Feller DR.
    Chirality; 1994 Aug; 6(2):76-85. PubMed ID: 7911313
    [Abstract] [Full Text] [Related]

  • 3. The tertiary amine nitrogen atom of piperazine sulfonamides as a novel determinant of potent and selective beta3-adrenoceptor agonists.
    Perrone MG, Bleve L, Santandrea E, Vitale P, Niso M, Scilimati A.
    ChemMedChem; 2009 Dec; 4(12):2080-97. PubMed ID: 19882697
    [Abstract] [Full Text] [Related]

  • 4. Structural and conformational features determining selective signal transduction in the beta 3-adrenergic receptor.
    Blin N, Camoin L, Maigret B, Strosberg AD.
    Mol Pharmacol; 1993 Dec; 44(6):1094-104. PubMed ID: 7903415
    [Abstract] [Full Text] [Related]

  • 5. The beta3-adrenoceptor agonist 4-[[(Hexylamino)carbonyl]amino]-N-[4-[2-[[(2S)-2-hydroxy-3-(4-hydroxyphenoxy)propyl]amino]ethyl]-phenyl]-benzenesulfonamide (L755507) and antagonist (S)-N-[4-[2-[[3-[3-(acetamidomethyl)phenoxy]-2-hydroxypropyl]amino]-ethyl]phenyl]benzenesulfonamide (L748337) activate different signaling pathways in Chinese hamster ovary-K1 cells stably expressing the human beta3-adrenoceptor.
    Sato M, Hutchinson DS, Evans BA, Summers RJ.
    Mol Pharmacol; 2008 Nov; 74(5):1417-28. PubMed ID: 18684840
    [Abstract] [Full Text] [Related]

  • 6. Mouse beta 3a- and beta 3b-adrenoceptors expressed in Chinese hamster ovary cells display identical pharmacology but utilize distinct signalling pathways.
    Hutchinson DS, Bengtsson T, Evans BA, Summers RJ.
    Br J Pharmacol; 2002 Apr; 135(8):1903-14. PubMed ID: 11959793
    [Abstract] [Full Text] [Related]

  • 7. Biochemical and pharmacological characterization of high-affinity trimetoquinol analogs on guinea pig and human beta adrenergic receptor subtypes: evidence for partial agonism.
    Fraundorfer PF, Fertel RH, Miller DD, Feller DR.
    J Pharmacol Exp Ther; 1994 Aug; 270(2):665-74. PubMed ID: 7915318
    [Abstract] [Full Text] [Related]

  • 8. Agonist interactions with chimeric and mutant beta1- and beta3-adrenergic receptors: involvement of the seventh transmembrane region in conferring subtype specificity.
    Granneman JG, Lahners KN, Zhai Y.
    Mol Pharmacol; 1998 May; 53(5):856-61. PubMed ID: 9584211
    [Abstract] [Full Text] [Related]

  • 9. Identification of potent agonists acting at an endogenous atypical beta3-adrenoceptor state that modulate lipolysis in rodent fat cells.
    Hamilton BS, Doods HN.
    Eur J Pharmacol; 2008 Feb 02; 580(1-2):55-62. PubMed ID: 18031735
    [Abstract] [Full Text] [Related]

  • 10. Close reciprocal regulation of beta 1- and beta 2-adrenergic receptors by dexamethasone in C6 glioma cells: effects on catecholamine responsiveness.
    Zhong H, Minneman KP.
    Mol Pharmacol; 1993 Dec 02; 44(6):1085-93. PubMed ID: 7903414
    [Abstract] [Full Text] [Related]

  • 11. Beta-adrenergic receptor subtypes that mediate ractopamine stimulation of lipolysis.
    Mills SE, Spurlock ME, Smith DJ.
    J Anim Sci; 2003 Mar 02; 81(3):662-8. PubMed ID: 12661646
    [Abstract] [Full Text] [Related]

  • 12. Iodinated analogs of trimetoquinol as highly potent and selective beta 2-adrenoceptor ligands.
    De Los Angeles JE, Nikulin VI, Shams G, Konkar AA, Mehta R, Feller DR, Miller DD.
    J Med Chem; 1996 Sep 13; 39(19):3701-11. PubMed ID: 8809159
    [Abstract] [Full Text] [Related]

  • 13. Functional characterization of the beta-adrenergic receptor subtypes expressed by CA1 pyramidal cells in the rat hippocampus.
    Hillman KL, Doze VA, Porter JE.
    J Pharmacol Exp Ther; 2005 Aug 13; 314(2):561-7. PubMed ID: 15908513
    [Abstract] [Full Text] [Related]

  • 14. Functional and pharmacological characterization of the natriuretic peptide-dependent lipolytic pathway in human fat cells.
    Moro C, Galitzky J, Sengenes C, Crampes F, Lafontan M, Berlan M.
    J Pharmacol Exp Ther; 2004 Mar 13; 308(3):984-92. PubMed ID: 14634036
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and adrenergic activity of a new series of N-aryl dicyclopropyl ketone oxime ethers: SAR and stereochemical aspects.
    Blanc M, Tamir A, Aubriot S, Michel MC, Bouzoubaa M, Leclerc G, Demenge P.
    J Med Chem; 1998 May 07; 41(10):1613-8. PubMed ID: 9572886
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the binding affinity of some newly synthesized phenylethanolamine and phenoxypropanolamine compounds at recombinant human beta- and alpha1-adrenoceptor subtypes.
    Ahmed M, Hanaoka Y, Kiso T, Kakita T, Ohtsubo Y, Muramatsu I, Nagatomo T.
    J Pharm Pharmacol; 2005 Jan 07; 57(1):75-81. PubMed ID: 15638996
    [Abstract] [Full Text] [Related]

  • 17. Differential activation of beta 1-, beta 2- and beta 3-adrenoceptors by catecholamines in white and brown adipocytes.
    Galitzky J, Carpéné C, Bousquet-Mélou A, Berlan M, Lafontan M.
    Fundam Clin Pharmacol; 1995 Jan 07; 9(4):324-31. PubMed ID: 8566931
    [Abstract] [Full Text] [Related]

  • 18. Tethered yohimbine analogs as selective human alpha2C-adrenergic receptor ligands.
    Bavadekar SA, Ma G, Mustafa SM, Moore BM, Miller DD, Feller DR.
    J Pharmacol Exp Ther; 2006 Nov 07; 319(2):739-48. PubMed ID: 16873606
    [Abstract] [Full Text] [Related]

  • 19. Relationship between stereochemistry and the beta3-adrenoceptor agonistic activity of 4'-hydroxynorephedrine derivative as an agent for treatment of frequent urination and urinary incontinence.
    Tanaka N, Tamai T, Mukaiyama H, Hirabayashi A, Muranaka H, Ishikawa T, Kobayashi J, Akahane S, Akahane M.
    J Med Chem; 2003 Jan 02; 46(1):105-12. PubMed ID: 12502364
    [Abstract] [Full Text] [Related]

  • 20. Novel sst(4)-selective somatostatin (SRIF) agonists. 2. Analogues with beta-methyl-3-(2-naphthyl)alanine substitutions at position 8.
    Erchegyi J, Penke B, Simon L, Michaelson S, Wenger S, Waser B, Cescato R, Schaer JC, Reubi JC, Rivier J.
    J Med Chem; 2003 Dec 18; 46(26):5587-96. PubMed ID: 14667213
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.